Pharmaceuticals, Biotechnology and Life Sciences
Serial entrepreneur and computer scientist Bryan Brandenburg advances biomedical and life extension simulation and visualization AI technologies at the helm…
RALEIGH, N.C.–(BUSINESS WIRE)–Arrevus Inc. (www.arrevus.com), a biotechnology company developing novel therapeutics for patients with unmet medical needs, today announced the…
NOTTINGHAM, England–(BUSINESS WIRE)–Tufts Center for the Study of Drug Development (CSDD) today published a white paper sharing study results that…
Providing new patient treatment options, accelerating development of life-changing medicines
Dendreon has completed enrollment of of 450 patients, in Phase 3 ProVent clinical trial testing Sipuleucel-T in men on active…
Trial Will Evaluate Safety and Efficacy of the Company’s Trappsol® Cyclo™ Drug in Alzheimer’s Disease GAINESVILLE, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc.…
LAVAL, Quebec–(BUSINESS WIRE)–#Altasciences–On behalf of the sponsor, Acurx Pharmaceuticals, Altasciences is proud to have successfully completed the clinical conduct,…
DARTMOUTH, Nova Scotia–(BUSINESS WIRE)–IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today…
Conference call scheduled today at 9:00 a.m. ET BURLINGTON, Mass.–(BUSINESS WIRE)–$ARQL #arql—ArQule, Inc. (Nasdaq: ARQL) today announced its financial results…
Total revenues of $57.6 billion, reflecting 9% growth. Loss per diluted share of $(3.99) and Adjusted Earnings per diluted share…